By developing and manufacturing innovative, easily manageable cold plasma therapy pens, the ActivCell Group is promoting the establishment of plasma medicine as an efficient treatment method in everyday medical practice. In cooperation with renowned European technology institutes and universities, ActivCell Group AG is making an important contribution to the research and ongoing development of this future-focused form of therapy in human and veterinary medicine.
The ActivCell-team
Dipl. Ing. ETH Thomas Fünfschilling
CEO
ActivCell Group AG
Dr Andrea Preuss
Head of Medical Division
Member of the Executive Board
ActivCell Group AGMember of the Executive Board
Dr Michael Hiestand
Head of Veterinary Division
Member of the Executive Board
ActivCell Group AGMember of the Executive Board
Daniele Scarabello
Manager Finance & Administration
ActivCell Group AG
Urs Laubscher
Quality Management, Regulatory Affairs
ActivCell Group AG
Dr FVH Heinz W. Burkhardt
Senior Expert Veterinary Market
ActivCell Group AG
Dr Selina Keller
Product and Sales Manager
ActivCell Group AGBoard of Directors
Ruedi Weber
Founder and member of the board of directors
Former founder and managing director SIA/SWB, previously Ruedi Weber + Architekten und Planer AG
ActivCell Group AGFormer founder and managing director SIA/SWB, previously Ruedi Weber + Architekten und Planer AG
Peter Weber
Founder and member of the board of directors
President of the board of directors peka-metall AG
ActivCell Group AGPresident of the board of directors peka-metall AG
Peter Frei
Founder and member of the board of directors
Management and proprietor IQF LLC
ActivCell Group AGManagement and proprietor IQF LLC
Careers at ActivCell Group AG
The ActivCell Group is a dynamic start-up company. We develop, produce and distribute innovative mobile cold plasma therapy devices in the form of handy pens.
Positions to be filled:
No vacancies at the moment
Unfortunately, we do not have any vacancies at the moment. However, we are always happy to receive unsolicited applications.
The history of the ActivCell Group
The motivation for founding ActivCell arose from the founders’ own experience with illness. Brothers Peter and Ruedi Weber struggled with ailments that were difficult to treat and did not respond to conventional therapies. In their search for alternatives, they came across high-frequency electrotherapy and experienced impressive healing successes.
Convinced that this therapy should have a more significant place in the medical world, Peter and Ruedi Weber decided to have the technology and its mechanisms of action researched and transferred into practice. At that time, there were no handy, mobile devices approved for medical use on the market for this form of therapy.
Determined to change this situation, Ruedi and Peter Weber founded ActivCell AG in 2014 together with Swiss engineers and scientists from the fields of medical technology and industrial design. The first handy, cordless prototypes for veterinary medicine were quickly developed.
The fact that these devices were also excellent sources of cold plasma and promised great benefits for the emerging field of plasma medicine gave clear direction to the disciplines of research and development for both veterinary and human medicine.
In 2017, the company launched its first devices for veterinary medicine. The devices were further developed according to market requirements and relaunched in 2020.
In the same year, ActivCell AG was renamed ActivCell Group AG and started the approval process for the use of the ActivCellpen in human medicine.